Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medtronic (NY:MDT)

90.97 -0.76 (-0.83%)
Official Closing Price Updated: 7:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
10 Magnificent S&P 500 Dividend Stocks Down Over 10% to Buy and Hold Forever
These S&P 500 dividend stocks have fallen by up to 33% and are best buys now. 
Via The Motley Fool
Topics Stocks
Got $200? 2 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Sarepta Therapeutics Crashes 26% After A Third Gene Therapy Patient Dies
The move wiped out all of the gains Sarepta lodged Thursday after announcing its restructuring plans. 
Via Investor's Business Daily
Topics Death Stocks
Novartis Makes A Bearish Move As One Of Its Bread-And-Butter Drugs Misses
The company's second biggest product missed sales expectations. Shares look likely to undercut a buy zone. 
Via Investor's Business Daily
Topics Government Stocks
CMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says Analysts
Via Stocktwits
Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Miss
The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts. 
Via Investor's Business Daily
Topics Government Stocks
MEDTRONIC PLC (NYSE:MDT) – A Potential Undervalued Opportunity in Healthcare
MEDTRONIC PLC (NYSE:MDT) appears undervalued with strong profitability, a solid dividend, and stable financials, making it a candidate for value investors. 
Via Chartmill
Sarepta To Lay Off 500 Employees After Two Patient Deaths; Shares Catapult
The company is also restructuring with the hopes of saving $400 million in expenses. 
Via Investor's Business Daily
Topics Death Earnings Government
Not Just a Patch Earns FDA, EU Clearance for CGM Patches Line, Expanding Diabetes Support Offerings
Via Press Release Distribution Service
Analyst Expectations For Medtronic's Future
 
Via Benzinga
Nvidia To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
MEDTRONIC PLC (NYSE:MDT) – A Reliable Dividend Stock Worth Considering
MEDTRONIC PLC (NYSE:MDT) offers a solid 3.18% dividend yield, strong profitability, and reasonable valuation, making it a candidate for dividend investors. The company has a reliable payout history and... 
Via Chartmill
5 Robotics Stocks to Buy for the Future of Automation
Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing. 
Via MarketBeat
Topics Artificial Intelligence
Bank Of America Loves These 8 Stocks For Third Quarter—And Says To Dump These 2 Fast
Bank of America names its highest-conviction stock ideas for Q3 2025—8 Buys and 2 Underperforms. Boeing, Cisco, and Datadog top the list. 
Via Benzinga
Medtronic Stock Is Climbing Friday: What's Going On?
CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward broader adoption. 
Via Benzinga
The Best High Yield Medical Device Stock to Invest $1,000 in Right Now
Via The Motley Fool
What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill
A steady dose of quality companies will keep your portfolio growing big and strong. 
Via The Motley Fool
Topics Intellectual Property
1 No-Brainer Dividend Stock to Buy Now and Hold Forever
Via The Motley Fool
Topics Government World Trade
Medtronic Names CFO For New Diabetes Company Ahead Of Intended Spin-Off
Chad Spooner’s appointment will be effective July 14, and he will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives. 
Via Stocktwits
Merit Medical Names Medtronic Veteran Martha Aronson As Next CEO, Projects Strong Outlook
Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates. 
Via Benzinga
Merit Medical Stock Soars After Hours As Better-Than-Expected Q2 Guidance Outweighs CEO Exit
The company expects second-quarter revenue to grow by as much as 14% year-over-year, with foreign exchange headwinds expected to trim approximately $2.3 million from the top line. 
Via Stocktwits
Bond Introduces World’s First Perpetual Smart Ring with Patent-Pending LifeDrive System
Via Get News
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process. 
Via Investor's Business Daily
3 Safe Buy-and-Hold Dividend Stocks With Strong Balance Sheets
These 3 dividend stocks offer strong balance sheets, low debt, and reliable payouts, making them solid long-term picks for income investors 
Via MarketBeat
Topics Lawsuit
This Oracle Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
 
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss Medtronic Stock
 
Via Benzinga
Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever
Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them. 
Via The Motley Fool
G3 Partners Opens Procomer Office in Silicon Valley to Accelerate U.S. Investment into Costa Rica
Via Press Release Distribution Service
FDA Sounds Alarm After 33 Injuries Tied To Medtronic Device Malfunction
FDA highlights risks from recalled Medtronic devices tied to esophageal injuries and faulty cannulas, with serious health concerns and product warnings issued. 
Via Benzinga
Abbott, Dexcom Draw Retail Buzz As RFK Jr. Urges Americans To Embrace Health Wearables
Retail sentiment surged on Stocktwits, with message volume jumping 1,600% for Abbott and 750% for Dexcom. 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.